Protective effect of ethanolic Feronia elephantum Correa fruit extract on high-fat diet induced steatohepatitis in rats

Main Article Content

Maruni Wiwin Diarti
Khoviya Yuwina Selinada Harmi
Dwi Nur Ahsani

Abstract

BACKGROUND
A high-fat diet can lead to hyperlipidemia which will end up as liver damage (steatohepatitis). Ethanolic Feronia elephantum Correa fruit extract (EFEC) has an antioxidant activity which is expected to overcome hyperlipidemia in the liver. The objective of this study was to determine the effects of EFEC on liver function and morphological changes in rats.

METHODS
This was an experimental study with a post-test only group design. A total of 20 male Wistar rats aged 2-4 months were randomized into 5 groups, A= negative control, B= positive control (high fat diet + 10 mg/kgBW simvastatin), C = high fat diet + 500 mg/kgBW EFEC fruit extract, D = high fat diet + 600 mg/kgBW EFEC, and E = high fat diet + 700 mg/kgBW EFEC). High-fat diet was given for 4 weeks (quail egg yolks, 10ml/200gBW). EFEC was administered for 4 weeks after induction of hypercholesterolemia. Examination of liver serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) was performed on rat blood serum and histopathological examination was carried out using steatohepatitis grading. One way ANOVA test and Post-Hoc Tamhane’s test were used to analyze the data.

RESULTS
Administration of EFEC at 700 mg/kgBW improved the liver enzymes (p=0.00 for SGPT and SGOT) and steatohepatitis grading in high-fat diet induced rats (mild condition, E = 75% vs A = 100% mild)

CONCLUSION
Ethanolic Feronia elephantum Correa fruit extract at 700 mg/kgBW was able to improve steatohepatitis in high-fat diet induced rats.

Article Details

How to Cite
Diarti, M. W., Harmi, K. Y. S., & Ahsani, D. N. (2021). Protective effect of ethanolic Feronia elephantum Correa fruit extract on high-fat diet induced steatohepatitis in rats. Universa Medicina, 40(1), 36–44. https://doi.org/10.18051/UnivMed.2021.v40.36-44
Section
Original Articles

References

Ferramosca A, Di Giacomo M, Zara V. Antioxidant dietary approach in treatment of fatty liver: New insights and updates. World J Gastroenterol 2017;23:4146–57. doi: 10.3748/wjg.v23.i23.4146.

Bril F, Sninsky JJ, Baca AM, et al. Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD. J Clin Endocrinol Metab 2016;101:644–52. doi: 10.1210/jc.2015-3111.

Méndez-Sánchez N, Cerda-Reyes E, et al. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. F1000Res 2020;9:56. doi: 10.12688/f1000research.21918.1.

Han JM, Kim HI, Lee YJ, Lee JW, Kim KM, Bae JC. Differing associations between fatty liver and dyslipidemia according to the degree of hepatic steatosis in Korea. J Lipid Atheroscler 2019;8:258. doi: 10.12997/jla.2019.8.2.258.

Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol 2017;9:715–32. doi: 10.4254/wjh.v9.i16.715.

López-Amador, Nolasco-Hipolito R, de J. Rojas-Jimeno M, Carvajal- Zarrabal O. Liver enzymes in patients diagnosed with non-alcoholic fatty liver disease (NAFLD) in Veracruz: a comparative analysis with the literature. Clin Invest 2017;7:11–6.

Schmidt B, Scaglione S, Ding X. Elevated liver enzymes in a young man with hyperlipidemia. Gastroenterology 2019;157:e6–8. https://doi.org/10.1053/j.gastro.2019.07.018.

Krishan S. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. Diabetes Metab Syndr Clin Res Rev 2016;10:S77–81. http://dx.doi.org/10.1016/j.dsx.2016.01.034.

Rattanachaisit P, Susantitaphong P, Thanapirom K, et al. Statin use and histopathological change in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Asian Biomed 2018;12:3–13. doi: https://doi.org/10.1515/abm-2018-0026.

Shattat GF. A review article on hyperlipidemia: types, treatments and new drug targets. Biomed Pharmacol J 2014;7:399–409. doi : https://dx.doi.org/10.13005/bpj/504.

Sohouli MH, Fatahi S, Sayyari A, Olang B, Shidfar F. The associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study. J Nutr Sci 2020;7:1–7. doi: 10.21203/rs.3.rs-24074/v1.

Casas-Grajales S, Muriel P. Antioxidants in liver health. World J Gastrointest Pharmacol Ther 2015;6:59. doi: 10.4292/wjgpt.v6.i3.59.

Pradhan D, Tripathy G, Patanaik S. Anticancer activity of Limonia acidissima Linn (Rutaceae) fruit extracts on human breast cancer cell lines. Trop J Pharm Res 2012;11:413–9.

Raharja KT. Kawista fruit prevents the increase of serum malondialdehyde level in Wistar Rats exposed to cigarette smoke. J K B 2017;29:190-5. doi: http://dx.doi.org/10.21776/ub.jkb.2017.029.03.2.

Pandit K, Mishra R, Brijesh S, Bhagwat A, Bhatt P. Lipid lowering activity of Feronia limonia leaf in Triton WR-1339 (Tyloxapol) induced hyperlipidemic rats. Int J Pharm Pharm Sci 2014;6:156–8.

Vasant RA, Narasimhacharya AV. Limonia fruit as a food supplement to regulate fluoride-induced hyperglycaemia and hyperlipidaemia. J Sci Food Agric 2013;93:422–6. doi: 10.1002/jsfa.5762.

Charan J, Kantharia N. How to calculate sample size in animal studies? J Pharmacol Pharmacother 2013;4:303–6. doi: 10.4103/0976-500X.119726.

Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 2016;65:1080–6. doi:10.1016/j.metabol.2015.11.008.

Ilango K, Chitra V. Wound healing and anti-oxidant activities of the fruit pulp of Limonia acidissima Linn (Rutaceae) in rats. Trop J Pharm Res 2010;9:223–30.

Rakhunde PB, Saher S, Ali SA. Neuroprotective effect of Feronia limonia on ischemia reperfusion induced brain injury in rats. Indian J Pharmacol 2014;46:617–21. doi: 10.4103/0253-7613.144920.

Sharma P, Bodhankar SL, Thakurdesai PA. Protective effect of aqueous extract of Feronia elephantum correa leaves on thioacetamide induced liver necrosis in diabetic rats. Asian Pac J Trop Biomed 2012;2:691–5.

Adak M. Protective role of antioxidants in alcoholic liver disease. Med Phoenix 2018;3:75–88.

Li S, Tan HY, Wang N, et al. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci 2015;16:26087–124. doi: 10.3390/ijms161125942.

Appak-Baskoy S, Cengiz M, Teksoy O, Ayhanci A. Dietary antioxidants in experimental models of liver diseases. In: Strawberry pre- and post-harvest management tech high fruit quality. Boston: IntechOpen; 2019;pp.1–22. doi: 10.5772/intechopen.83485.

Xiang C, Teng Y, Yao C, et al. Antioxidant properties of flavonoid derivatives and their hepatoprotective effects on CCl4 induced acute liver injury in mice. RSC Adv 2018;8:15366–71.

Darsini DTP, Maheshu V, Srinivasan P, Nishaa S, Castro J. Dietary supplementation of Limonia acidissima L. fruit on in vivo antioxidant activity and lipid peroxidation of Cyprinus carpio L. IPCBEE 2013;57:73–9.